<b>EBS Technologies</b> Appoints <b>Karl Schweitzer</b> As Chief Executive Officer Post author:Sam Post published:August 27, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like How This Drug Candidate Could be a Winner in Gilead's Pipeline March 20, 2017 Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017 Belgium Biotech Ablynx Files For $150 Million U.S. IPO Right After Phase III Boost October 2, 2017
Fortress Biotech Forms Subsidiary Tamid Bio to Develop Novel AAV Gene Therapies in Orphan Disease… December 4, 2017